Ocular Therapeutix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OCUL and other ETFs, options, and stocks.About OCUL
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC.
CEOPravin U. Dugel
CEOPravin U. Dugel
Employees274
Employees274
HeadquartersBedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded2006
Founded2006
Employees274
Employees274
OCUL Key Statistics
Market cap2.52B
Market cap2.52B
Price-Earnings ratio-8.23
Price-Earnings ratio-8.23
Dividend yield—
Dividend yield—
Average volume2.81M
Average volume2.81M
High today$12.36
High today$12.36
Low today$11.60
Low today$11.60
Open price$12.08
Open price$12.08
Volume2.50M
Volume2.50M
52 Week high$16.44
52 Week high$16.44
52 Week low$5.79
52 Week low$5.79
Stock Snapshot
The current Ocular Therapeutix(OCUL) stock price is $11.85, with a market capitalization of 2.52B. The stock trades at a price-to-earnings (P/E) ratio of -8.23.
As of 2026-01-04, Ocular Therapeutix(OCUL) stock has fluctuated between $11.60 and $12.36. The current price stands at $11.85, placing the stock +2.2% above today's low and -4.1% off the high.
The Ocular Therapeutix(OCUL)'s current trading volume is 2.5M, compared to an average daily volume of 2.81M.
During the past year, Ocular Therapeutix(OCUL) stock moved between $5.79 at its lowest and $16.44 at its peak.
During the past year, Ocular Therapeutix(OCUL) stock moved between $5.79 at its lowest and $16.44 at its peak.
Analyst ratings
100%
of 13 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own OCUL. This list is generated using Robinhood data, and it’s not a recommendation.